Role of Montelukast in Preventing Relapse in Childhood Idiopathic Nephrotic Syndrome
Status:
Completed
Trial end date:
2020-05-30
Target enrollment:
Participant gender:
Summary
The investigators planned this research to elucidate if there is any efficacy of montelukast,
a leukotriene receptor antagonist, in steroid sensitive childhood onset NS to help prevent
relapses. This study was done to know the role of leukotriene receptor antagonist (LTRA)
montelukast in preventing relapses in idiopathic childhood nephrotic syndrome (NS)